Cell Biology: Research & TherapyISSN: 2324-9293

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Perspective, Cell Biol Vol: 12 Issue: 3

Cellular Insights into CRISPR-Cas9 in Precision Medicine

Yioz Weing*

1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA

*Corresponding Author: Yioz Weing,
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA

Received date: 02 September, 2023, Manuscript No. CBRT-23-116138;

Editor assigned date: 04 September, 2023, PreQC No CBRT-23-116138 (PQ);

Reviewed date: 18 September, 2023, QC No CBRT-23-116138;

Revised date: 25 September, 2023, Manuscript No CBRT-23-116138 (R);

Published date: 05 October, 2023, DOI: 10.4172/2324-9293.1000186.

Citation: Weing Y (2023) Cellular Insights into CRISPR-Cas9 in Precision Medicine. Cell Biol 12:3.


Precision medicine has revolutionized the field of healthcare by tailoring treatments to individual patients' genetic makeup. Among the various technologies enabling this revolution, the CRISPR-Cas9 gene editing system stands out as a powerful tool for cellular-level precision.

Precision medicine seeks to provide patients with tailored treatments that consider their unique genetic variations, improving efficacy and reducing side effects. The CRISPR-Cas9 system, a breakthrough in gene editing, has become a linchpin in the pursuit of precision medicine by enabling precise genome modifications at the cellular level.

Cellular mechanisms of Crispr-cas9

DNA cleavage and repair: CRISPR-Cas9 uses guide RNA sequences to target specific genes within the genome. Cas9, an endonuclease, which makes Double-Strand Breaks (DSBs) at the target site. Cellular repair mechanisms, such as Non-Homologous End Joining (NHEJ) or Homology-Directed Repair (HDR), are subsequently activated to repair the DSB.

Cellular response to CRISPR-Cas9: Understanding how cells respond to CRISPR-Cas9 is crucial for minimizing off-target effects and optimizing editing efficiency. Cellular factors like p53 and play roles in Deoxyribonucleic Acid (DNA) damage response pathways, influencing the outcome of CRISPR-Cas9 editing.

Cellular insights informing precision medicine: Target Identification: Cell biology techniques are essential for identifying precise targets for CRISPR-Cas9 editing. Single-cell RNA sequencing and proteomics help researchers pinpoint genes and proteins involved in disease pathways. These insights guide the selection of therapeutic targets.

Genetic variations: Cellular studies reveal the diversity of genetic variations among individuals. CRISPR-Cas9 can be adapted to correct or modulate these variations, allowing for personalized therapies. Cellular models, such as patient-derived induced Pluripotent Stem Cells (iPSCs), enable researchers to assess the efficacy of these edits.

Disease modeling: Cellular insights have led to the development of disease-specific cellular models. CRISPR-Cas9 can introduce diseaseassociated mutations into these models to study disease mechanisms and test potential therapies. This approach accelerates drug discovery and development.

Applications in precision medicine

Cancer therapy: Cellular insights into CRISPR-Cas9 have fueled the development of cancer immunotherapies. CAR-T cell therapies, for example, use CRISPR-Cas9 to engineer patient-derived T cells to target cancer-specific antigens, improving the precision and efficacy of treatment.

Inherited genetic disorders: Cellular models derived from patientspecific iPSCs are instrumental in studying and correcting genetic mutations causing disorders like cystic fibrosis and muscular dystrophy. CRISPR-Cas9 holds promise for personalized gene therapy in these conditions.

Neurodegenerative diseases: Cellular insights have enabled the development of cellular models for neurodegenerative diseases like Alzheimer's and Parkinson's. CRISPR-Cas9 is used to introduce disease-related mutations, aiding in drug discovery and potential gene therapies.

Challenges and future directions: While cellular insights have propelled CRISPR-Cas9 to the forefront of precision medicine, challenges remain. Off-target effects, delivery methods, and ethical considerations require ongoing research and innovation. Additionally, expanding the use of CRISPR-Cas9 to more complex diseases and tissues poses exciting yet complex prospects.


Cellular insights into CRISPR-Cas9 have catalyzed advancements in precision medicine. By understanding the cellular mechanisms and responses to gene editing, researchers are optimizing this technology for therapeutic applications. CRISPR-Cas9's potential to target specific genes at the cellular level is ushering in a new era of personalized medicine, offering hope to patients with a wide range of diseases. As it continues to unlock cellular insights, the path to precision medicine becomes increasingly promising.

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination